Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report

INTRODUCTION: Hepatitis C virus reinfection occurs universally after liver transplantation with accelerated cirrhosis rates of up to 30% within 5 years after liver transplantation. Management of hepatitis C virus reinfection is complicated by drug interactions and pre-treatment. Dual antiviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Knapstein, Johanna, Wörns, Marcus A, Galle, Peter R, Zimmermann, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110930/
https://www.ncbi.nlm.nih.gov/pubmed/25047566
http://dx.doi.org/10.1186/1752-1947-8-257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110930/
https://www.ncbi.nlm.nih.gov/pubmed/25047566
http://dx.doi.org/10.1186/1752-1947-8-257

Ejemplares similares